Nano Holdings, Inc. (TYO:4571)
108.00
-3.00 (-2.70%)
Jun 3, 2026, 3:30 PM JST
Nano Holdings Revenue
In the fiscal year ending March 31, 2026, Nano Holdings had annual revenue of 174.00M JPY with 61.11% growth. Nano Holdings had revenue of 44.00M in the quarter ending March 31, 2026, with 76.00% growth.
Revenue
174.00M
Revenue Growth
+61.11%
P/S Ratio
52.79
Revenue / Employee
8.70M
Employees
20
Market Cap
9.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 174.00M | 66.00M | 61.11% |
| Mar 31, 2025 | 108.00M | -27.00M | -20.00% |
| Mar 31, 2024 | 135.00M | -67.00M | -33.17% |
| Mar 31, 2023 | 202.00M | 84.18M | 71.45% |
| Mar 31, 2010 | 117.82M | -235.83M | -66.68% |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 6.59B |
| Immuno-Biological Laboratories | 1.00B |
| MEDINET | 998.00M |
| OncoTherapy Science | 808.00M |
| Carna Biosciences | 619.35M |
| Stella Pharma | 323.00M |
| CellSeed | 161.00M |
| ADR120S | 50.00M |